MRNA vs UFPT · rev $145.0M vs P/E 26, rev $148.9M
Moderna Inc (MRNA) versus UFP Technologies Inc (UFPT) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
UFP Technologies Inc (UFPT) is a medical devices company listed on NASDAQ.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported UFPT revenue for 2025-12-31 was $148.9M. Net income was $17.6M. Revenue was down 1.5% from 2025-06-30 to 2025-12-31. UFPT currently screens at market cap $1.76B and trailing P/E 26.0.
MRNA currently screens at market cap $24.52B. UFPT currently screens at market cap $1.76B and trailing P/E 26.0.
Not investment advice. Open the MRNA and UFPT stock pages for the full models.
Not investment advice.